- Home
- XXI vs HTGC Comparison
XXI vs HTGC Comparison
Compare XXI & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | XXI | HTGC |
|---|---|---|
| Founded | 2025 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.2B |
| IPO Year | 2026 | 2004 |
Fundamental Metrics
Financial Performance| Metric | XXI | HTGC |
|---|---|---|
| Price | $6.75 | $16.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $19.50 |
| AVG Volume (30 Days) | ★ 1.8M | 1.1M |
| Earning Date | 11-11-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 11.18% |
| EPS Growth | N/A | ★ 14.91 |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.32 |
| Revenue Next Year | N/A | $7.07 |
| P/E Ratio | ★ N/A | $18.86 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.15 | $13.70 |
| 52 Week High | $11.49 | $19.13 |
Technical Indicators
Market Signals| Indicator | XXI | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 60.86 | 38.79 |
| Support Level | $5.66 | $16.37 |
| Resistance Level | $7.45 | $17.15 |
| Average True Range (ATR) | 0.37 | 0.29 |
| MACD | 0.04 | -0.10 |
| Stochastic Oscillator | 80.42 | 9.77 |
Price Performance
Historical ComparisonAbout XXI Twenty One Capital Inc. Class A Common Stock
Twenty One Capital Inc is engaged in the Bitcoin-related business lines. It engages in two principal activities: actively accumulating Bitcoin and managing its Bitcoin holdings, and commencing development of educational materials and branded content intended to drive increased institutional and retail investor Bitcoin literacy.
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.